Wrong Smartphone Settings Can Lead to Missed Alerts From Linked Diabetes Devices

Medically reviewed by Drugs.com.

By Stephanie Brown HealthDay Reporter

TUESDAY, Feb. 11, 2025 -- The U.S. Food and Drug Administration is urging all patients with smartphone-compatible diabetes devices to check their phone configurations to ensure all safety alerts are being received.

The FDA notice concerns continuous glucose monitors, insulin pumps, and automated insulin dosing systems that rely on a smartphone to deliver critical safety alerts. The agency has received reports that patients are not receiving or hearing the alerts even though they thought the alerts had been configured for delivery.

In a safety communication, the FDA offers several suggestions for users of the devices, including turning off automatic operating system (OS) updates and not updating the smartphone's OS until confirming the diabetes device app is compatible with the new version; after updating the phone's OS or adding a new accessory, carefully monitoring the medical device app to make sure alerts are received and can be heard as expected; checking that the smartphone alerts are configured as expected at least once a month; and, if alerts are not being received as expected from the mobile medical app, calling the technical support number for the medical device for assistance.

"Modern medical devices, such as diabetes devices that connect to a smartphone, can provide users with the convenience and flexibility to configure alerts that are personalized to them. However, users should stay aware of alert settings and monitor these devices to ensure they continue to receive critical alerts as expected," Courtney Lias, director of the Office of In Vitro Diagnostic Products in the FDA Center for Devices and Radiological Health, said in an agency news release. "Even if configured correctly, certain hardware or software changes can interrupt the expected operation of these critical devices, which can lead to patient harm if undetected."

The FDA is working with diabetes-related medical device manufacturers to ensure smartphone alert configurations of devices are carefully evaluated before patient use and that any updates to recommended configurations are communicated quickly and clearly to users.

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords